Columbus Macro LLC Purchases New Stake in Colgate-Palmolive Company $CL

Columbus Macro LLC purchased a new stake in shares of Colgate-Palmolive Company (NYSE:CL) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 104,385 shares of the company’s stock, valued at approximately $8,249,000.

A number of other large investors have also added to or reduced their stakes in CL. S.A. Mason LLC raised its stake in shares of Colgate-Palmolive by 3.9% during the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after acquiring an additional 130 shares during the last quarter. Security National Bank of Sioux City Iowa IA grew its stake in shares of Colgate-Palmolive by 0.8% in the third quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock worth $1,298,000 after purchasing an additional 130 shares during the last quarter. Stratos Wealth Advisors LLC grew its stake in shares of Colgate-Palmolive by 4.5% in the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after purchasing an additional 130 shares during the last quarter. Chicago Partners Investment Group LLC increased its holdings in Colgate-Palmolive by 1.5% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company’s stock valued at $724,000 after purchasing an additional 136 shares during the period. Finally, Cary Street Partners Investment Advisory LLC increased its holdings in Colgate-Palmolive by 17.7% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 911 shares of the company’s stock valued at $83,000 after purchasing an additional 137 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer owned 55,310 shares in the company, valued at $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sally Massey sold 15,851 shares of the stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the sale, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 184,683 shares of company stock worth $17,486,693 over the last three months. Company insiders own 0.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Rothschild & Co Redburn set a $93.00 price objective on Colgate-Palmolive in a report on Friday, February 13th. Jefferies Financial Group boosted their target price on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Evercore lifted their price target on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $94.75.

Colgate-Palmolive Trading Down 0.0%

Shares of NYSE CL opened at $84.25 on Monday. The firm’s 50 day moving average price is $91.11 and its 200-day moving average price is $83.37. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The company has a market cap of $67.59 billion, a PE ratio of 32.16, a P/E/G ratio of 3.78 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter last year, the firm earned $0.91 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, equities research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio is 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.